NCT06608186 2025-01-22
PPOS
Benha University
Phase 1/2 Completed
Clinical Trials
12 trialsNCT04727671 2023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.
Damascus University
Phase 4 Completed
NCT04727684 2023-10-24
Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI
Damascus University
Phase 4 Completed
NCT04071574 2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2 Completed
NCT05847660 2023-05-06
Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient
Fayoum University
Phase NA Unknown
NCT05751681 2023-03-02
Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI
Zagazig University
Phase NA Unknown
NCT05112692 2021-11-09
Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
Mansoura University
Phase NA Unknown
NCT04993924 2021-10-13
GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst
Assaf-Harofeh Medical Center
Phase 4 Unknown
NCT04094467 2020-03-25
Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection
Assiut University
Phase 4 Unknown
NCT01402336 2017-10-10
GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer
Seoul National University Hospital
Phase 3 Completed
NCT01185704 2014-02-13
ATTAC-PCO
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT00746031 2010-10-25
Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids
University of Edinburgh
Phase 4 Completed